Aging-US Peer-Reviewed Journal Publishes Open-Access Longevity Research
Aging-US consolidates the field's most credible longevity science in one open-access venue — making peer-reviewed aging research freely available to anyone who can act on it.
Explanation
Aging-US is a peer-reviewed scientific journal focused primarily on the biology of aging. "Peer-reviewed" means every paper is vetted by independent experts before publication — a quality filter that separates signal from noise in a field notorious for hype. "Open-access" means the full text is free to read, no institutional paywall required.
Why does this matter now? The longevity space is flooded with supplements, protocols, and startup claims that outrun the evidence. A dedicated, credible journal creates a reference point — a place where practitioners, investors, and curious insiders can check whether a claim has actually survived scientific scrutiny.
The journal's aging-first focus is the real differentiator. General biomedical journals treat aging as a sub-topic; Aging-US treats it as the domain. That specialization attracts researchers who might otherwise scatter findings across dozens of outlets, gradually building a denser, more cross-referenced body of work.
For anyone tracking longevity as a technology or investment thesis, the practical move is simple: use Aging-US as a primary filter. If a breakthrough isn't published or cited there (or in its peer tier), treat the claim with proportional skepticism. What to watch: whether the journal's citation impact grows as the longevity sector matures — that would signal it's becoming the field's canonical record, not just one venue among many.
Aging-US sits within the Impact Journals portfolio and operates on an open-access model funded primarily through article processing charges (APCs), a structure that removes reader-side paywalls while shifting cost to authors or their institutions. For a field where translational speed matters — bench findings need to reach clinicians, biotech founders, and policymakers fast — open access is a structural advantage, not just an ethical posture.
The journal's scope spans molecular mechanisms (senescence, telomere dynamics, mitochondrial dysfunction), systems-level aging phenotypes, and increasingly, interventional studies on geroprotective compounds such as rapamycin analogs, senolytics, and NAD+ precursors. This breadth is deliberate: aging is a systems problem, and siloing findings by mechanism slows cross-domain synthesis.
Peer review in this space carries specific weight because the longevity field has a reproducibility problem. High-profile lifespan extension results in model organisms (C. elegans, Drosophila, mice) frequently fail to translate across labs or species. A journal with rigorous review standards acts as a partial corrective — though it's worth noting that peer review catches methodology errors more reliably than it catches subtle p-hacking or publication bias toward positive results.
The open-access angle also has a compounding effect on citation velocity: freely available papers accumulate citations faster, which feeds journal impact factor, which attracts higher-quality submissions — a flywheel that matters for whether Aging-US becomes the field's canonical venue or remains one node in a distributed publication ecosystem.
Key open question: as longevity research industrializes (more biotech funding, more clinical trials), will Aging-US expand its clinical trial publication capacity, or will that work migrate to higher-impact general journals like Nature Aging or Cell? The answer will determine whether it leads the field's evidentiary record or curates its preclinical layer.
Reality meter
Time horizon
Community read
Glossary
- article processing charges (APCs)
- Fees paid by authors or their institutions to publish in open-access journals, replacing traditional reader subscription costs. This model removes paywalls for readers while shifting publication costs upstream to authors.
- senescence
- The process of cellular aging in which cells lose the ability to divide and function properly, contributing to tissue deterioration and aging phenotypes in organisms.
- senolytics
- A class of drugs designed to selectively eliminate senescent cells (aged, non-dividing cells) from tissues, with the goal of reducing age-related dysfunction and extending healthspan.
- NAD+ precursors
- Compounds that boost levels of NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in cellular energy metabolism and aging-related processes; examples include NMN and NR.
- p-hacking
- A research practice where analysts manipulate data analysis or selectively report results to achieve statistically significant findings, inflating false positive rates and reducing reproducibility.
- impact factor
- A metric measuring the average number of citations received by articles in a journal, used to rank journal prestige and influence within a field.
Sources
- Tier 3 Peer-Reviewed Aging Research Journal | Aging-US
- Tier 3 Longevity Science Is Overhyped. But This Research Really Could Change Humanity.
- Tier 3 11 Rising Stars Shaping the Future of Longevity - Business Insider
- Tier 3 A cheap drug used by longevity enthusiasts may have a surprising impact on exercise
- Tier 3 Scientists boost lifespan by 70% in elderly male mice using simple drug combo | ScienceDaily
- Tier 3 Next gen cancer drug shows surprising anti aging power | ScienceDaily
- Tier 3 The Future of Longevity: Innovations in Aging Research - IMJ Health Blog
- Tier 3 A long and ongoing look at the secrets of human longevity and healthy aging | ScienceDaily
- Tier 3 Healthy Aging News -- ScienceDaily
- Tier 3 Amid the Hype, Longevity Science Shows Some Progress – HotAir
- Tier 3 It’s never too late: Just moving more could add years to your life | ScienceDaily
- Tier 3 This method to reverse cellular aging is about to be tested in humans | Scientific American
- Tier 1 This method to reverse cellular ageing is about to be tested in humans
- Tier 3 Timeline of aging research - Wikipedia
- Tier 3 A hidden cellular cleanup trick could reverse aging | ScienceDaily
- Tier 3 Scientists may have found how to reverse memory loss in aging brains | ScienceDaily
- Tier 3 Scientists reversed brain aging and memory loss in mice | ScienceDaily
- Tier 3 New nasal spray reverses brain aging while restoring memory, giving new hope to people with dementia
- Tier 1 Daily briefing: A treatment to reverse cellular ageing is about to be tested in people
- Tier 3 Brain Research breakthrough: Nasal Spray Reverses Aging Effects
- Tier 3 Life Extension Treatments: A New Era in Anti-Aging (2026)
- Tier 3 Clinical trial for Longevity drug meets goal of enrolling 1000 dogs | dvm360
- Tier 3 Home lifespan | Lifespan Research Institute
- Tier 3 FDA determines drug for lifespan extension in large dogs to have a Reasonable Expectation of Effectiveness | dvm360
- Tier 3 Second drug for canine healthy lifespan extension receives FDA support | dvm360
- Tier 3 Seragon Publishes Record-Breaking SRN-901 Longevity Data, Demonstrating 33% Lifespan Extension in Mice
- Tier 3 Scientists bet on longevity to unlock a longer lifespan for humans | MEXC News
- Tier 3 Can aging be slowed? Some academic scientists think so | AAMC
- Tier 3 Reconsidering GLYNAC: What the Evidence Actually Says About Glycine, NAC, Reversing Aging, and Life Extension - New Life Longevity
- Tier 3 dsm-firmenich unveils science-backed longevity innovations at Vitafoods Europe 2026
- Tier 3 Serum protein profiling reveals hallmark-level aging trajectories and strain-specific resilience in CB6F1J and C57BL/6J male mice | bioRxiv
- Tier 1 Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets | Signal Transduction and Targeted Therapy
- Tier 3 Organelle resilience as a comparative blueprint for longevity | EMBO Molecular Medicine | Springer Nature Link
- Tier 3 The Hallmarks of Aging and Senescence
- Tier 3 The 14 Hallmarks of Aging: How NAD+ Plays a Role in Every Hallmark
- Tier 3 The Hallmarks of Aging
- Tier 3 Blue zone - Wikipedia
- Tier 3 Home - Live Better, Longer - Blue Zones
- Tier 3 Origins of the Blue Zones and Longevity Secrets - Blue Zones Project
- Tier 3 Blue Zones longevity claims may rest on flawed records, essay argues
- Tier 3 Are Blue Zones Debunked? - by Sarah Ballantyne, PhD
- Tier 3 How people in Blue Zones live longer, and the 5 habits ...
- Tier 3 Lessons from Blue Zones: Diet & Lifestyle for Longevity
- Tier 3 Are Blue Zones Real? A New Scientific Definition for Longevity Hotspots Could Be a Game Changer.
- Tier 3 Scientists set a formal definition for "Blue Zones" | EurekAlert!
- Tier 3 Blue zones: New rules define where people truly live the longest - Earth.com
Prediction
Will Aging-US become a top-5 cited journal specifically within longevity and aging research by 2027?
Vote
Your vote feeds topic weights, community direction and future prioritisation. Open community direction